Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2014
10/16/2014US20140309177 Compositions and methods for the induction and tuning of gene expression
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140309173 Peptides For Skin Rejuvenation And Methods Of Using The Same
10/16/2014US20140309172 Ice inhibiting compounds and uses thereof
10/16/2014US20140309170 Anti-angiogenic peptides and uses thereof
10/16/2014US20140309169 Methods and Compositions for Inhibiting Delayed Graft Function
10/16/2014US20140309167 Combination of active ingredients for the treatment of acute kidney injury
10/16/2014US20140309161 Modified antibiotic peptides having variable systemic release
10/16/2014US20140309159 Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders
10/16/2014US20140308744 Compositions of Active WNT Protein
10/16/2014US20140308369 Dietary product intended to reduce visceral fat during the pre-operative phase prior to bariatric surgery
10/16/2014US20140308367 Methods of treating gram-negative microbial infections
10/16/2014US20140308358 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
10/16/2014US20140308342 Reprogramming urokinase into an antibody-recruiting anticancer agent
10/16/2014US20140308339 Lipophilic drug delivery vehicle and methods of use thereof
10/16/2014US20140308332 Compositions and Methods for Spine Fusion Procedures
10/16/2014US20140308303 Method for selecting a candidate drug compound
10/16/2014US20140308299 Combination Immunotherapy for the Treatment of Cancer
10/16/2014US20140308296 PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
10/16/2014US20140308293 Reconstitution method for high concentration dry protein formulations
10/16/2014US20140308289 Extracellular histones as biomarkers for prognosis and molecular targets for therapy
10/16/2014US20140308280 Factor VIII Polypeptide Formulations
10/16/2014US20140308275 Methods for diagnosing and treating myhre syndrome
10/16/2014US20140308267 Neurotoxins exhibiting shortened biological activity
10/16/2014US20140308266 Modified neurotoxins with poly-glycine and uses thereof
10/16/2014US20140308264 VEGF Analogs and Methods of Use
10/16/2014US20140308260 Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
10/16/2014US20140308256 Methods for Use of Neural Stem Cell Compositions for Treatment of Central Nervous System Lesions
10/16/2014US20140308251 Intervertebral disc repair, methods and devices therefor
10/16/2014US20140308248 Dietary Supplement System for Multifunctional Anti-Aging Management and Method of Use
10/16/2014US20140308244 Combination Therapy for Treatment of Inflammatory Demyelinating Disease
10/16/2014US20140308242 Biomarkers for hcv infected patients
10/16/2014US20140308240 Therapeutic agent for infections, and treatment method using same
10/16/2014US20140308239 Chimeric cytokine formulations for ocular delivery
10/16/2014US20140308237 Use of Inclusion Bodies as Therapeutic Agents
10/14/2014US8862224 Method for treating neovascularization
10/14/2014US8860979 Deletion of unwanted reply messages in e-mail printing
10/14/2014US8859807 Glutathione preparation and method for production thereof
10/14/2014US8859802 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/14/2014US8859733 Compositions and methods for promoting wound healing and tissue regeneration
10/14/2014US8859731 Selective modification of proteins
10/14/2014US8859729 Growth hormone releasing peptides
10/14/2014US8859728 Peptides that target dorsal root ganglion neurons
10/14/2014US8859727 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
10/14/2014US8859725 Healthy kidney biomarkers
10/14/2014US8859723 Peptidomimetic macrocycles
10/14/2014US8859706 Bioactive hydrogel
10/14/2014US8859593 Composition for improving cognition and memory
10/14/2014US8859562 Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer
10/14/2014US8859537 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
10/14/2014US8859526 Methods for treating bleeding disorders using sulfated polysaccharides
10/14/2014US8859523 Crosslinked compounds and methods of making and using thereof
10/14/2014US8859520 Methods for therapy of neurodegenerative disease of the brain
10/14/2014US8859507 Protein complex for intracellular delivery and uses thereof
10/14/2014US8859506 Glycopeptide phosphonate derivatives
10/14/2014US8859505 Cysteine protease inhibitors
10/14/2014US8859504 Boronate ester compounds and pharmaceutical compositions thereof
10/14/2014US8859503 Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity
10/14/2014US8859502 Therapy for MLL-rearranged leukemia
10/14/2014US8859500 Method for ameliorating pain by modification of NMDA receptors through inhibition of SRC
10/14/2014US8859499 Method of enhancing efficacy of blood transfusions
10/14/2014US8859498 Targeted therapeutic proteins
10/14/2014US8859497 Method of treatment using cysteine mutants of beta interferon
10/14/2014US8859496 Pharmaceutical composition using connective-tissue growth factor
10/14/2014US8859495 Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
10/14/2014US8859494 Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
10/14/2014US8859493 Insulin derivatives
10/14/2014US8859492 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
10/14/2014US8859491 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
10/14/2014US8859489 Water-mediated control of depolymerization step of glatiramer acetate synthesis
10/14/2014US8859488 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
10/14/2014US8859284 Delivery of nanoparticles to neurons
10/14/2014US8859273 Methods of using HCN genes to treat cardiac arrhythmias
10/14/2014US8859252 Prostatic acid phosphatase, compositions comprising the same, and methods for producing and/or purifying the same
10/14/2014US8859251 Oligoadenylate synthetase (OAS)
10/14/2014US8859240 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
10/14/2014US8859234 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
10/14/2014US8859223 Compositions and methods for imaging beta-secretase activity in living cells and organisms
10/14/2014US8859197 Sperm-specific cation channel, CATSPER3, and uses therefor
10/14/2014US8859004 pH-sensitive nanoparticles for oral insulin delivery
10/14/2014US8858998 Thermoresponsive arginine-based hydrogels as biologic carriers
10/14/2014US8858987 Wound dressing for the controlled release of therapeutic agents
10/14/2014US8858985 Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer
10/14/2014US8858983 Antioxidants and antimicrobial accessories including antioxidants
10/14/2014US8858968 Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
10/14/2014US8858957 GAS57 mutant antigens and GAS57 antibodies
10/14/2014US8858936 Compositions with hematopoietic and immune activity
10/14/2014US8858927 Method for protection of peptides or proteins against non-enzymatic deamidation
10/14/2014US8858925 Pegylated fibrinogen precursor molecule
10/14/2014US8858915 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
10/14/2014US8858912 Frozen compositions and methods for piercing a substrate
10/09/2014WO2014165853A1 Inhibitors of metastasis
10/09/2014WO2014165780A2 Matrix metalloproteinases and uses thereof
10/09/2014WO2014165617A1 Mesoporous alum nanoparticles as universal platform for antigen adsorption, presentation, and delivery
10/09/2014WO2014165607A2 Aromatic-cationic peptide formulations, compositions and methods of use
10/09/2014WO2014165563A2 Uses of cyclic peptides for treating and preventing atherosclerosis
10/09/2014WO2014165552A2 Fibulin protein variants and corresponding nucleic acid sequences
10/09/2014WO2014165448A1 NOVEL α4β7 PEPTIDE DIMER ANTAGONISTS
10/09/2014WO2014165240A1 Synbodies for detection of human norovirus
10/09/2014WO2014165181A1 Compositions for treatment of retinal detachment
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 3163